Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac allograft vasculopathy: current concepts

H O Ventura1, F W Smart, D D Stapleton

  • 1Ochsner Medical Institutions, New Orleans, LA 70121.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|May 1, 1993
PubMed
Summary

Cardiac allograft vasculopathy, a major cause of late death in heart transplant patients, is a unique intimal hyperplastic process. Retransplantation is the only current definitive therapy, but results are fair.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emission Characteristics and Effect of Battery Drain in "Budget" Curing Lights.

Operative dentistry·2015
Same author

Current status of adult spinal deformity.

Global spine journal·2014
Same author

Albert Ochsner, MD: Chicago Surgeon and Mentor to Alton Ochsner.

Ochsner journal·2011
Same author

Obesity and the "obesity paradox" in cardiovascular diseases.

Clinical pharmacology and therapeutics·2011
Same author

Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation.

Transplantation proceedings·2005

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • Cardiac allograft vasculopathy (CAV) is the leading cause of late mortality in heart transplant recipients, affecting 15-20% of patients.
  • CAV is distinct from traditional atherosclerosis, characterized by concentric intimal hyperplasia, intact internal elastic lamina, and rare calcification.

Purpose of the Study:

  • To describe the characteristics, potential causes, diagnostic methods, and treatment of cardiac allograft vasculopathy.

Main Methods:

  • Review of existing literature on cardiac allograft vasculopathy.
  • Comparison of diagnostic modalities including coronary angiography, intravascular ultrasound, and coronary angioscopy.
  • Evaluation of retransplantation as a therapeutic option.

Main Results:

Related Experiment Videos

  • CAV typically affects the distal coronary arteries, leading to rapid occlusion.
  • Immunologic and non-immunologic endothelial damage may drive the myointimal proliferation seen in CAV.
  • Intravascular ultrasound and coronary angioscopy show higher sensitivity for CAV detection than coronary angiography.

Conclusions:

  • Cardiac allograft vasculopathy presents unique pathological features compared to atherosclerosis.
  • While retransplantation is the only definitive treatment, its success rates are currently limited.